FDA Inspection 1056541 — XGen Pharmaceuticals DJB, Inc.

XGen Pharmaceuticals DJB, Inc. — FEI 3005548067

The FDA completed an inspection of XGen Pharmaceuticals DJB, Inc. on Jun 22, 2018 in Horseheads, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 22, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Horseheads, NY (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed
433621 CFR 211.150Written distribution procedure
438921 CFR 211.198(a)Procedures to be written and followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.